Unknown

Dataset Information

0

Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO© ).


ABSTRACT: This study demonstrates the quantitative characteristics of the first patient-reported outcome (PRO) tool developed for patients with nontransfusion-dependent β-thalassemia (NTDT), the NTDT-PRO© . A multicenter validation study was performed over 24 weeks, involving 48 patients from Italy, Lebanon, Greece, and Thailand. Most patients were female (68.8%), with a median age of 34.5 years (range, 18-52); 66.7% were diagnosed with β-thalassemia intermedia, and median time since diagnosis was 22 years (range, 0-43). The NTDT-PRO comprises 6 items across 2 domains (Tiredness/Weakness and Shortness of Breath [SoB]), and was valid and reliable, with good consistency. At baseline, most patients reported symptoms as present via the NTDT-PRO, and were highly compliant, ≥90% completing the NTDT-PRO tool. In a pairwise correlation analysis, all items were positively correlated. Correlations between NTDT-PRO and existing tools-36-Item Short Form Health Survey version 2 (SF-36v2) and Functional Assessment of Cancer Therapy-Anemia (FACT-An)-were assessed at weeks 1, 3, and 12; robust correlations were seen between SoB and SF-36v2-Vitality (rs  = -0.53), and between SoB and Fact-An-Fatigue Experience (rs  = -0.66) at week 1. Internal consistency was high for both Tiredness/Weakness (Cronbach alpha, 0.91) and SoB (Spearman-Brown coefficient, 0.78); intraclass correlation coefficients were high (Tiredness/Weakness, 0.88 and 0.97; SoB, 0.92 and 0.98), demonstrating stability. Further studies are required to fully support the validity of this tool, this study demonstrated the usefulness of the NTDT-PRO in the clinical setting and for longitudinal clinical research, particularly in trials where patient health-related quality of life is expected to change.

SUBMITTER: Taher A 

PROVIDER: S-EPMC6587834 | biostudies-other | 2019 Feb

REPOSITORIES: biostudies-other

altmetric image

Publications

Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO<sup>©</sup> ).

Taher Ali A   Cappellini Maria Domenica MD   Viprakasit Vip V   Sutcharitchan Pranee P   Mahmoud Dalia D   Laadem Abderrahmane A   Khan Anzalee A   Gwaltney Chad C   Harding Gale G   Attie Kenneth K   Zhang Xiaosha X   Zou Jun J   Pariseau Joseph J   Henry Hu X X   Kattamis Antonis A  

American journal of hematology 20181126 2


This study demonstrates the quantitative characteristics of the first patient-reported outcome (PRO) tool developed for patients with nontransfusion-dependent β-thalassemia (NTDT), the NTDT-PRO<sup>©</sup> . A multicenter validation study was performed over 24 weeks, involving 48 patients from Italy, Lebanon, Greece, and Thailand. Most patients were female (68.8%), with a median age of 34.5 years (range, 18-52); 66.7% were diagnosed with β-thalassemia intermedia, and median time since diagnosis  ...[more]

Similar Datasets

| S-EPMC6587527 | biostudies-other
| S-EPMC5413279 | biostudies-literature
| S-EPMC6966844 | biostudies-literature
| S-EPMC7250143 | biostudies-literature
| S-EPMC7448958 | biostudies-literature
| S-EPMC8579900 | biostudies-literature
| S-EPMC9673004 | biostudies-literature
| S-EPMC9325227 | biostudies-literature
| S-EPMC7506039 | biostudies-literature
| S-EPMC5859646 | biostudies-literature